Thermogenesis Holdings, Inc. (THMO): Price and Financial Metrics
THMO Price/Volume Stats
| Current price | $1.36 | 52-week high | $22.78 |
| Prev. close | $1.34 | 52-week low | $1.20 |
| Day low | $1.36 | Volume | 850 |
| Day high | $1.36 | Avg. volume | 740,513 |
| 50-day MA | $2.06 | Dividend yield | N/A |
| 200-day MA | $5.08 | Market Cap | 2.59M |
THMO Stock Price Chart Interactive Chart >
THMO POWR Grades
- Value is the dimension where THMO ranks best; there it ranks ahead of 96% of US stocks.
- THMO's strongest trending metric is Sentiment; it's been moving up over the last 151 days.
- THMO's current lowest rank is in the Stability metric (where it is better than 3.84% of US stocks).
THMO Stock Summary
- THERMOGENESIS HOLDINGS INC's market capitalization of $2,456,544 is ahead of only 0.26% of US-listed equities.
- In terms of volatility of its share price, THMO is more volatile than 97.81% of stocks we're observing.
- THERMOGENESIS HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -286.99%, greater than the shareholder yield of only 1.95% of stocks in our set.
- Stocks that are quantitatively similar to THMO, based on their financial statements, market capitalization, and price volatility, are NMRD, BVN, AGE, MPAA, and EBIX.
- THMO's SEC filings can be seen here. And to visit THERMOGENESIS HOLDINGS INC's official web site, go to www.thermogenesis.com.
THMO Valuation Summary
- THMO's EV/EBIT ratio is -1.3; this is 110.83% lower than that of the median Healthcare stock.
- THMO's price/sales ratio has moved down 8.9 over the prior 243 months.
Below are key valuation metrics over time for THMO.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| THMO | 2023-05-23 | 0.3 | 0.4 | -0.2 | -1.3 |
| THMO | 2023-05-22 | 0.3 | 0.5 | -0.2 | -1.3 |
| THMO | 2023-05-19 | 0.3 | 0.5 | -0.2 | -1.3 |
| THMO | 2023-05-18 | 0.3 | 0.6 | -0.2 | -1.4 |
| THMO | 2023-05-17 | 0.3 | 0.6 | -0.2 | -1.4 |
| THMO | 2023-05-16 | 0.3 | 0.6 | -0.2 | -1.4 |
THMO Growth Metrics
- Its year over year net income to common stockholders growth rate is now at 23.2%.
- The 5 year net income to common stockholders growth rate now stands at 61.35%.
- Its 3 year revenue growth rate is now at -3.04%.
The table below shows THMO's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 10.225 | -6.427 | -10.492 |
| 2022-06-30 | 11.268 | -6.477 | -9.026 |
| 2022-03-31 | 10.44 | -6.827 | -10.877 |
| 2021-12-31 | 9.294 | -6.62 | -11.379 |
| 2021-09-30 | 8.823 | -8.828 | -11.575 |
| 2021-06-30 | 8.02 | -10.684 | -12.264 |
THMO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- THMO has a Quality Grade of D, ranking ahead of 11.36% of graded US stocks.
- THMO's asset turnover comes in at 0.381 -- ranking 53rd of 75 Measuring and Control Equipment stocks.
- COHU, MKSI, and KLAC are the stocks whose asset turnover ratios are most correlated with THMO.
The table below shows THMO's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.381 | 0.510 | -0.584 |
| 2021-03-31 | 0.398 | 0.059 | -0.764 |
| 2020-12-31 | 0.513 | 0.129 | -0.788 |
| 2020-09-30 | 0.542 | 0.101 | -1.088 |
| 2020-06-30 | 0.636 | 0.120 | -1.093 |
| 2020-03-31 | 0.784 | 0.446 | -0.594 |
THMO Price Target
For more insight on analysts targets of THMO, see our THMO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $6.00 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Thermogenesis Holdings, Inc. (THMO) Company Bio
Thermogenesis Holdings, Inc. serves customers in the United States.
Latest THMO News From Around the Web
Below are the latest news stories about THERMOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate THMO as an investment opportunity.
Q1 2023 Thermogenesis Holdings Inc Earnings CallQ1 2023 Thermogenesis Holdings Inc Earnings Call |
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2023 and provided a corporate strategic update. |
ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2023 and provide a corporate strategic update on Monday, May 15, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET. |
Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue EstimatesUltragenyx (RARE) delivered earnings and revenue surprises of -18.27% and 4.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Stock's 52% Dive Might Signal An Opportunity But It Requires Some ScrutinyThermoGenesis Holdings, Inc. ( NASDAQ:THMO ) shareholders won't be pleased to see that the share price has had a very... |
THMO Price Returns
| 1-mo | -29.17% |
| 3-mo | -50.36% |
| 6-mo | -71.33% |
| 1-year | -92.44% |
| 3-year | -99.49% |
| 5-year | -99.36% |
| YTD | -57.50% |
| 2022 | -92.96% |
| 2021 | -51.67% |
| 2020 | -52.50% |
| 2019 | 64.79% |
| 2018 | -91.10% |
Loading social stream, please wait...